Trial register facet
Phase 2b trial records
8 records at phase 2b.
Showing 0 records on this page
Records
8 documents
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| DANU-PH2B-OBESITY | Danuglipron | Phase 2b | Programme discontinued | Randomised, double-blind, placebo-controlled | 605 | 2023 | Not rated |
| DANU-PH2B-T2D | Danuglipron | Phase 2b | Programme discontinued | Randomised, double-blind, placebo-controlled | 411 | 2023 | Not rated |
| DANU-PH2B-OBESITY-QOLprogramme record | Danuglipron | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-T2D-BODY-COMPprogramme record | Danuglipron | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| CELIAC-PH2B | Larazotide acetate | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | 342 | 2015 | Moderate |
| AOD-PH2B-OBESITY | AOD-9604 | Phase 2b | Programme discontinued | Randomised, double-blind, placebo-controlled | 536 | 2007 | Not rated |
| AOD-PH2B-OBESITY-QOLprogramme record | AOD-9604 | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Very low |
| AOD-PH2B-OBESITY-BODY-COMPprogramme record | AOD-9604 | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2007 | Very low |